Companies Castle Biosciences Inc

Castle Biosciences (CSTL): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Castle Biosciences Inc’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

CEO total pay$6,786,771CEO Derek Maetzold · source

Say-on-pay support94.32%Latest vote · source

CEO vs. named peers1st pct.Of 5 peer CEOs

CEO pay ratio52:1To the median employee · source

CEO pay, last three years

$1,605,984FY2023
$6,941,074FY2024
$6,786,771FY2025

CEO total pay was $6,786,771 in fiscal 2025, down from $6,941,074 in fiscal 2024.

FY2025: salary $751,350 · bonus $0 · stock awards $4,977,208 · option awards $0

Executives and directors

Derek Maetzold · CEO Frank Stokes · CFO Kristen Oelschlager · COO Tobin Juvenal · CCO Daniel M. Bradbury · Chair of the Board Ellen Goldberg · Independent Director G. Bradley Cole · Independent Director Kimberlee S. Caple · Independent Director Miles D. Harrison · Independent Director Rodney Cotton · Independent Director Tiffany P. Olson · Independent Director

Frequently asked questions

Who was the highest-paid executive at Castle Biosciences Inc in fiscal 2025?

As disclosed, Derek Maetzold (President and Chief Executive Officer) was the highest-paid executive at Castle Biosciences Inc in fiscal 2025, with total compensation of $6,786,771.

How does Castle Biosciences Inc's chief executive pay compare to its disclosed peer group?

As disclosed, Derek Maetzold's total compensation ranked at the 1st percentile of Castle Biosciences Inc's disclosed peer group.

What is Castle Biosciences Inc's CEO-to-median employee pay ratio?

As disclosed, Castle Biosciences Inc's CEO-to-median employee pay ratio was 52:1.

How did shareholders vote on Castle Biosciences Inc's executive compensation?

As disclosed, 94.32% of shareholders supported Castle Biosciences Inc's executive compensation in the latest say-on-pay vote.

How much does Castle Biosciences Inc spend in total on board compensation for fiscal 2025?

As disclosed, Castle Biosciences Inc reported total board compensation of $2,062,447 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table

Named executive officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension / NQDC	All other	Total
Derek Maetzold	$751,350	$0	$4,977,208	$0	$1,036,863	$0	$21,350	$6,786,771
President and Chief Executive Officer
Frank Stokes	522,544	14,370	1,417,918	0	374,769	0	90,236	2,419,837
Chief Financial Officer
Kristen Oelschlager	529,204	14,553	1,417,918	0	379,545	0	21,350	2,362,571
Chief Operating Officer
Tobin Juvenal	529,204	14,553	1,417,918	0	379,545	0	21,350	2,362,571
Chief Commercial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officer	FY2025 total	FY2024 total	FY2023 total	Δ FY2024→2025
Derek Maetzold	$6,786,771	$6,941,074	$1,605,984	↓ −154,303
Frank Stokes	2,419,837	2,306,525	880,250	↑ +113,312
Kristen Oelschlager	2,362,571	2,446,931	828,484	↓ −84,360
Tobin Juvenal	2,362,571	2,446,931	829,099	↓ −84,360

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is designed to align incentive-based compensation with Company performance. We believe that our compensation policies and procedures are generally aligned with the long-term interests of our stockholders.

CEO STI target (% of salary)	100%
CEO LTI target (% of salary)	—
Independent consultant	AON (AON's Human Capital Solutions Practice, a division of AON plc)
Clawback policy	True
Anti-hedging	True
Anti-pledging	True

Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

Executive	Award	Grant date	Threshold	Target	Granted	Maximum	Grant-date fair value
Derek Maetzold	PSU	2025-03-04	—	111,948	—	—	$2,488,604
Tobin Juvenal	PSU	2025-03-04	—	15,946	—	—	354,480
Kristen Oelschlager	PSU	2025-03-04	—	15,946	—	—	354,480
Tobin Juvenal	RSU	2025-03-04	—	—	47,838	—	1,063,439
Derek Maetzold	RSU	2025-03-04	—	—	111,948	—	2,488,604
Kristen Oelschlager	RSU	2025-03-04	—	—	47,838	—	1,063,439
Frank Stokes	RSU	2025-03-04	—	—	47,838	—	1,063,439
Frank Stokes	PSU	2025-03-04	—	15,946	—	—	354,480

Vehicle mix — grant-date fair value by award type

Named executive officer	Time-vested (RSU)	Performance-vested (PSU)	Options / SARs	% performance-vested
Derek Maetzold	$2,488,604	$2,488,604	$0	50.0%
Tobin Juvenal	1,063,439	354,480	0	25.0%
Kristen Oelschlager	1,063,439	354,480	0	25.0%
Frank Stokes	1,063,439	354,480	0	25.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

Executive	Award	Shares unvested	Exercise price	Market value unvested
Frank Stokes	PSU	8,124	—	$316,024
Tobin Juvenal	PSU	9,207	—	358,152
Kristen Oelschlager	PSU	9,207	—	358,152
Frank Stokes	RSU	14,617	—	568,601
Frank Stokes	PSU	15,946	—	620,299
Tobin Juvenal	PSU	15,946	—	620,299
Kristen Oelschlager	PSU	15,946	—	620,299
Tobin Juvenal	RSU	15,961	—	620,883
Kristen Oelschlager	RSU	15,961	—	620,883
Derek Maetzold	RSU	33,496	—	1,302,994
Frank Stokes	RSU	36,558	—	1,422,106
Tobin Juvenal	RSU	41,432	—	1,611,705
Kristen Oelschlager	RSU	41,432	—	1,611,705
Frank Stokes	RSU	47,838	—	1,860,898
Tobin Juvenal	RSU	47,838	—	1,860,898
Kristen Oelschlager	RSU	47,838	—	1,860,898
Derek Maetzold	PSU	62,218	—	2,420,280
Derek Maetzold	RSU	93,328	—	3,630,459
Derek Maetzold	RSU	111,948	—	4,354,777
Derek Maetzold	PSU	111,948	—	4,354,777

Director compensation

Director	Cash fees	Stock awards	Option awards	Non-equity incentive	All other	Total
Rodney CottonIndependent · Audit · Compensation	$66,519	$250,763	$0	$0	$0	$317,282
Daniel M. BradburyIndependent · Board Chair	97,056	217,169	0	0	0	314,225
G. Bradley ColeIndependent · Audit (Chair) · Compensation	76,519	217,169	0	0	0	293,688
Ellen GoldbergIndependent · Compensation (Chair) · Nominating and Corporate Governance	69,113	217,169	0	0	0	286,282
Tiffany P. OlsonIndependent · Audit · Nominating and Corporate Governance (Chair)	69,019	217,169	0	0	0	286,188
Miles D. HarrisonIndependent · Compensation · Nominating and Corporate Governance	66,425	217,169	0	0	0	283,594
Kimberlee S. CapleIndependent · Audit · Compensation · Nominating and Corporate Governance	64,019	217,169	0	0	0	281,188
Derek J. MaetzoldEmployee director	0	0	0	—	0	0

Board fee structure and ownership guideline

Annual cash retainer	$50,000
Annual equity retainer	$250,000
Per board meeting fee	—
Committee chair fees (audit / comp / nom-gov)	20,000 / 20,000 / 10,000
Stock ownership guideline	$3

Total cost of the board

Component	FY2025
Cash retainers and fees	$508,670
Equity awards (grant-date value)	$1,553,777
All other compensation	$0
Total cost of the board	$2,062,447

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Castle Biosciences as a peer

Companies that benchmark against CSTL

10 companies name CSTL as a compensation peer

908 Devices Inc.MASSFY2025
Adaptive Biotechnologies CorpADPTFY2025
CareDx, Inc.CDNAFY2025
Fulgent Genetics, Inc.FLGTFY2025
GeneDx Holdings Corp.WGSFY2025
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACBFY2025
Personalis, Inc.PSNLFY2025
Quanterix CorpQTRXFY2025
STANDARD BIOTOOLS INC.LABFY2025
TREACE MEDICAL CONCEPTS, INC.TMCIFY2025

Each company listed discloses CSTL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CSTL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

WGS GeneDx Holdings Corp.CKTB Cytek Biosciences, Inc.NVTAQ Invitae CorporationMVRVI Maravai Lifesciences Holdings, Inc.NTRA Natera, Inc.

Peer reciprocity

The companies Castle Biosciences Inc names as compensation peers that name it back in their own disclosed peer groups.

GeneDx Holdings Corp. (WGS)²³¹

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

Rank	Company	FY	Chief executive	Salary	Stock awards	Option awards	Non-equity incentive	Total
1	Natera, Inc.	2025	Steven Chapman	$853,710	$12,979,558	$0	$1,114,151	$14,957,319
2	GeneDx Holdings Corp.	2025	Katherine Stueland	715,869	11,738,600	0	1,075,500	13,547,219
3	Castle Biosciences Inc	2025	Derek Maetzold	751,350	4,977,208	0	1,036,863	6,786,771
—	Cytek Biosciences, Inc.	—	—	—	—	—	—	not in coverage universe
—	Invitae Corporation	—	—	—	—	—	—	not in coverage universe
—	Maravai Lifesciences Holdings, Inc.	—	—	—	—	—	—	not in coverage universe

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

Company	Annual incentive payout	Long-term vehicle mix	PSU measures include TSR	Compensation consultant
Castle Biosciences Inc	138%	RSU 50 · PSU 50	No	AON (AON's Human Capital Solutions Practice, a division of AON plc)
Cytek Biosciences, Inc.	not disclosed	not disclosed	not disclosed	not disclosed
GeneDx Holdings Corp.	150%	PSU 50 · RSU 50	No	Pearl Meyer
Invitae Corporation	not disclosed	not disclosed	not disclosed	not disclosed
Maravai Lifesciences Holdings, Inc.	not disclosed	not disclosed	not disclosed	not disclosed
Natera, Inc.	131.1%	PSU 50 · RSU 50	No	Aon

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio

Meeting year	Meeting date	For	Against	Abstain	Support	Outcome
2026	2026-05-28	21,280,180	1,281,394	11,857	94.32%	Passed
2025	2025-05-22	19,986,768	1,314,254	43,158	93.83%	Passed
2024	2024-05-23	20,622,511	306,249	299,389	98.54%	Passed
2023	2023-05-25	8,962,410	11,098,410	41,701	44.68%	Failed
2022	2022-06-02	8,331,458	11,985,739	433,449	41.01%	Failed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting year	Meeting date	Approval — company’s computation
2026	2026-05-28	94.32%^a
2025	2025-05-22	93.83%^b
2024	2024-05-23	98.54%^c

a. Approved under the standard stated in the filing — “ion of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 "FOR" votes from a majority of the votes cast on the matter (excluding abstentions and broker non-votes) No effect Not applicable (1) 3 Advisory approval of the compensation of our NEOs "FOR" votes from a majority of the votes cast on the matter (excluding abstentions and broker non-votes) No effect No effect 4 Approval of the Company's non-employee director compensation policy "FOR" votes from a majority of the votes cast on the matter (excluding abstentions and broker non-votes) No effect No effect (1) This proposal is considered to be a "rout revoke your proxy at any time before the final vote at the Annual Meeting.”.

b. Voting standard not stated in the filing.

c. Approved under the standard stated in the filing — “Abstentions will have no effect on Proposal 1.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)	52 : 1
CEO total compensation	$6,786,771
Median employee compensation	$130,759

Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

Insider	Role	Transaction date	Code	Shares	Price	Value	Security	Source
Derek J. Maetzold	Director	2026-05-07	D	1,159	$22	$25,591	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-07	D	237	22	5,233	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-07	D	41	23	926	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	273	20	5,461	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	322	20	6,441	Common	Form 4 ↗
Dividend-equivalent accruals		2026-05-20	—	130	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-05-20	A	130	2	311	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	130	20	2,600	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	1,035	20	20,903	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	A	420	2	1,004	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Dividend-equivalent accruals		2026-05-21	—	420	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-05-21	D	420	20	8,482	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	880	20	17,772	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-05-21	A	11,210	3	37,890	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-05-21	D	11,210	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Dividend-equivalent accruals		2026-06-01	—	204	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	1,153	21	24,048	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	6,010	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	A	6,010	2	14,364	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	6,214	21	129,605	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	A	204	2	488	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	1,357	21	28,303	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	1,153	21	23,821	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	1,357	21	28,036	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	550	21	11,363	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Dividend-equivalent accruals		2026-06-15	—	550	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	A	550	2	1,315	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-06-16	D	8,587	21	177,837	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-07-01	D	400	25	9,912	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-07-01	D	8,186	24	199,738	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	1,357	24	32,962	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	6,214	24	150,938	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	A	6,214	2	14,851	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	6,214	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	1,153	24	28,006	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	1,153	23	26,427	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	1,357	23	31,102	Common	Form 4 ↗
Dividend-equivalent accruals		2026-07-14	—	550	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	A	550	2	1,315	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	550	23	12,606	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	1,110	24	26,784	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	1,307	24	31,538	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	232	25	5,814	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	50	25	1,253	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	A	6,214	2	14,851	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	6,214	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	43	25	1,078	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	5,982	24	144,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	6,480	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	1,690	30	50,957	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	7,270	30	215,039	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	6,480	30	195,385	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	8,149	29	235,033	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	1,891	30	57,229	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	A	6,480	2	15,487	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	1,983	30	59,791	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	A	10,664	2	25,487	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	4,486	30	134,580	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	3,000	29	87,360	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	1,100	31	33,682	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	3,597	30	109,180	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	10,664	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	4,232	30	128,454	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	10,664	30	323,684	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-03	D	1,730	28	48,873	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	20,356	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	2,866	31	88,238	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	8,421	31	259,266	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	A	20,356	2	48,651	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	11,935	31	373,995	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	3,374	31	103,879	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	4,782	31	149,849	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	4,063	31	127,318	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	2,546	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	A	2,546	2	6,085	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	2,546	31	78,114	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	473	31	14,512	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	556	31	17,059	Common	Form 4 ↗
Dividend-equivalent accruals		2026-08-14	—	1,100	—	—	1 insider, 1 accrual row
Derek J. Maetzold	Director	2026-08-14	A	1,100	2	2,629	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Frank Stokes	Chief Financial Officer	2026-08-14	D	24,908	30	741,511	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	2,714	30	81,474	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	1,100	30	33,022	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	2,306	30	69,226	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-17	D	1,730	30	51,191	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-24	D	12,218	34	411,588	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-25	D	7,161	34	245,357	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-25	D	9,050	35	317,112	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-25	D	5,223	35	180,920	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	12,428	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	A	12,428	2	29,703	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	956	34	32,389	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	2,505	33	83,016	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	209	34	7,081	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	2,129	33	70,555	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	11,472	33	380,182	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	177	34	5,997	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-31	D	1,730	33	56,761	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	200	34	6,804	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	4,152	0	0	Derivative, Class A Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	3,952	33	131,839	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	A	4,152	3	14,034	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	223	33	7,310	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	2,656	32	84,992	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	A	8,584	2	20,516	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	3,124	32	99,968	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	71	33	2,327	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	8,361	32	267,552	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	8,584	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	83	33	2,721	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-14	D	3,306	32	106,863	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-15	D	3,294	35	115,758	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	8,580	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	3,198	35	112,998	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	A	8,580	2	20,506	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	8,580	35	303,166	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	2,718	35	96,038	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-29	D	5,543	35	196,765	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-30	D	1,034	34	35,363	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	4,153	0	0	Derivative, Class A Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	1,346	36	48,967	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	2,807	36	100,350	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	A	4,153	3	14,037	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	8,580	36	305,156	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	A	8,165	2	19,514	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	8,165	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	2,718	36	96,668	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	3,198	36	113,740	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-12	D	3,288	34	110,608	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	2,718	32	86,731	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	3,198	32	102,048	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	8,580	32	273,788	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-26	D	3,288	33	108,767	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-28	D	1,237	36	44,009	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-28	D	5,341	37	195,582	Common	Form 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 200 transactions

Insider	Role	Transaction date	Code	Shares	Price	Value	Security	Source
Derek J. Maetzold	Director	2026-05-07	D	1,159	$22	$25,591	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-07	D	237	22	5,233	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-07	D	41	23	926	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	273	20	5,461	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	322	20	6,441	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	130	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	A	130	2	311	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	66	20	1,320	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-20	D	130	20	2,600	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	1,035	20	20,903	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	A	420	2	1,004	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	420	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	420	20	8,482	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	880	20	17,772	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-05-21	D	212	20	4,282	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-05-21	A	11,210	3	37,890	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-05-21	D	11,210	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-22	A	13,667	—	—	Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-22	D	13,667	0	0	Derivative, Class A Common	Form 4 ↗
G. Bradley Cole	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Kimberlee S. Caple	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Ellen Goldberg	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Rodney Cotton	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Daniel M. Bradbury	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Tiffany P. Olson	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Miles D. Harrison	Director	2026-05-28	A	11,766	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	204	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	278	21	5,798	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	1,153	21	24,048	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	6,010	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	A	6,010	2	14,364	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	6,214	21	129,605	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	A	204	2	488	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-01	D	1,357	21	28,303	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	1,153	21	23,821	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	1,357	21	28,036	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	550	21	11,363	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	550	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	D	278	21	5,743	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-06-15	A	550	2	1,315	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-06-16	D	8,587	21	177,837	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-07-01	D	400	25	9,912	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-07-01	D	8,186	24	199,738	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	1,357	24	32,962	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	6,214	24	150,938	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	A	6,214	2	14,851	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	6,214	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	278	24	6,753	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-01	D	1,153	24	28,006	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	1,153	23	26,427	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	1,357	23	31,102	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	550	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	A	550	2	1,315	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	550	23	12,606	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-14	D	278	23	6,372	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	1,110	24	26,784	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	1,307	24	31,538	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	232	25	5,814	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	50	25	1,253	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	A	6,214	2	14,851	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	6,214	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	10	25	251	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	268	24	6,467	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	43	25	1,078	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-27	D	5,982	24	144,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	6,480	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	1,690	30	50,957	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	7,270	30	215,039	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	6,480	30	195,385	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	8,149	29	235,033	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-07-31	D	1,891	30	57,229	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	A	6,480	2	15,487	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-07-31	D	1,983	30	59,791	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	A	10,664	2	25,487	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	4,486	30	134,580	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	3,000	29	87,360	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-03	D	1,100	31	33,682	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	3,597	30	109,180	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	10,664	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	4,232	30	128,454	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-03	D	10,664	30	323,684	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-03	D	1,730	28	48,873	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	20,356	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	2,866	31	88,238	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	8,421	31	259,266	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	A	20,356	2	48,651	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	11,935	31	373,995	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	3,374	31	103,879	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	4,782	31	149,849	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-04	D	4,063	31	127,318	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	2,546	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	A	2,546	2	6,085	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	2,546	31	78,114	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	473	31	14,512	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-05	D	556	31	17,059	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	1,100	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	A	1,100	2	2,629	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Frank Stokes	Chief Financial Officer	2026-08-14	D	24,908	30	741,511	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	2,714	30	81,474	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	1,100	30	33,022	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	278	30	8,346	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-14	D	2,306	30	69,226	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-17	D	1,730	30	51,191	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-24	D	12,218	34	411,588	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-25	D	7,161	34	245,357	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-25	D	9,050	35	317,112	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-08-25	D	5,223	35	180,920	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	12,428	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	A	12,428	2	29,703	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	956	34	32,389	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	2,505	33	83,016	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	21	34	711	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	209	34	7,081	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	2,129	33	70,555	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	257	33	8,517	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	11,472	33	380,182	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-08-28	D	177	34	5,997	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-08-31	D	1,730	33	56,761	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	200	34	6,804	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	4,152	0	0	Derivative, Class A Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	D	3,952	33	131,839	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-09-01	A	4,152	3	14,034	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	223	33	7,310	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	2,656	32	84,992	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	A	8,584	2	20,516	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	3,124	32	99,968	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	71	33	2,327	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	8,361	32	267,552	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	8,584	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-11	D	83	33	2,721	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-14	D	3,306	32	106,863	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-15	D	3,294	35	115,758	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	8,580	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	3,198	35	112,998	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	A	8,580	2	20,506	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	8,580	35	303,166	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-09-21	D	2,718	35	96,038	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-29	D	5,543	35	196,765	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-09-30	D	1,034	34	35,363	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	4,153	0	0	Derivative, Class A Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	1,346	36	48,967	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	D	2,807	36	100,350	Common	Form 4 ↗
Kristen Oelschlager	Chief Operating Officer	2026-10-01	A	4,153	3	14,037	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	8,580	36	305,156	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	A	8,165	2	19,514	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	8,165	0	0	Derivative, Class A Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	2,718	36	96,668	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-05	D	3,198	36	113,740	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-12	D	3,288	34	110,608	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	2,718	32	86,731	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	3,198	32	102,048	Common	Form 4 ↗
Derek J. Maetzold	Director	2026-10-19	D	8,580	32	273,788	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-26	D	3,288	33	108,767	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-28	D	1,237	36	44,009	Common	Form 4 ↗
Tobin Juvenal	Chief Commercial Officer	2026-10-28	D	5,341	37	195,582	Common	Form 4 ↗

Sources (231 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

Section 01, Derek Maetzold. DEF 14A, filed 2026-04-08. Section “SUMMARY COMPENSATION TABLE” · page 67. As printed: 6,786,771. View filing ↗
Section 01, Frank Stokes. DEF 14A, filed 2026-04-08. Section “SUMMARY COMPENSATION TABLE” · page 67. As printed: 2,419,837. View filing ↗
Section 01, Kristen Oelschlager. DEF 14A, filed 2026-04-08. Section “SUMMARY COMPENSATION TABLE” · page 67. As printed: 2,362,571. View filing ↗
Section 01, Tobin Juvenal. DEF 14A, filed 2026-04-08. Section “SUMMARY COMPENSATION TABLE” · page 67. As printed: 2,362,571. View filing ↗
Section 03, Derek Maetzold PSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Tobin Juvenal PSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Kristen Oelschlager PSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Tobin Juvenal RSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Derek Maetzold RSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Kristen Oelschlager RSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Frank Stokes RSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Frank Stokes PSU. DEF 14A, filed 2026-04-08. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 07, pay ratio. DEF 14A, filed 2026-04-08. Section “CEO Pay Ratio”. As printed: 52 : 1. View filing ↗
Section 08, Rodney Cotton. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 317,282. View filing ↗
Section 08, Daniel M. Bradbury. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 314,225. View filing ↗
Section 08, G. Bradley Cole. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 293,688. View filing ↗
Section 08, Ellen Goldberg. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 286,282. View filing ↗
Section 08, Tiffany P. Olson. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 286,188. View filing ↗
Section 08, Miles D. Harrison. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 283,594. View filing ↗
Section 08, Kimberlee S. Caple. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 281,188. View filing ↗
Section 08, Derek J. Maetzold. DEF 14A, filed 2026-04-08. Section “Director Compensation”. As printed: 0. View filing ↗
Section 02, Derek J. Maetzold 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-05-21. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-05-21. Form 4, filed 2026-05-26. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-05-21. Form 4, filed 2026-05-26. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Rodney Cotton 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Rodney Cotton 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ellen Goldberg 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tiffany P. Olson 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, G. Bradley Cole 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, G. Bradley Cole 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel M. Bradbury 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kimberlee S. Caple 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tiffany P. Olson 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Miles D. Harrison 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Miles D. Harrison 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kimberlee S. Caple 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ellen Goldberg 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel M. Bradbury 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, G. Bradley Cole 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kimberlee S. Caple 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Ellen Goldberg 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Rodney Cotton 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Daniel M. Bradbury 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tiffany P. Olson 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Miles D. Harrison 2026-05-28. Form 4, filed 2026-06-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-06-16. Form 4, filed 2026-06-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-14. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-27. Form 4, filed 2026-07-29. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-07-31. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-03. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-03. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-03. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Frank Stokes 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-08-17. Form 4, filed 2026-08-19. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-24. Form 4, filed 2026-08-26. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-25. Form 4, filed 2026-08-26. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-08-25. Form 4, filed 2026-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-08-25. Form 4, filed 2026-08-26. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-08-28. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-08-31. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-11. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-09-14. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-09-15. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-21. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-21. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-21. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-21. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-09-21. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-09-29. Form 4, filed 2026-10-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-09-30. Form 4, filed 2026-10-01. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Kristen Oelschlager 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-05. Form 4, filed 2026-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-05. Form 4, filed 2026-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-05. Form 4, filed 2026-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-05. Form 4, filed 2026-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-05. Form 4, filed 2026-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-10-12. Form 4, filed 2026-10-14. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-19. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-19. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Derek J. Maetzold 2026-10-19. Form 4, filed 2026-10-21. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-10-26. Form 4, filed 2026-10-28. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-10-28. Form 4, filed 2026-10-30. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Tobin Juvenal 2026-10-28. Form 4, filed 2026-10-30. Insider equity transaction reported since the proxy statement. View filing ↗
Section 06, 2026 vote. Form 8-K, filed 2026-05-29. Item 5.07 · say-on-pay result. As reported: 94.32% (votes for as printed: 21,280,180). View filing ↗
Section 06, 2025 vote. Form 8-K, filed 2025-05-23. Item 5.07 · say-on-pay result. As reported: 93.83% (votes for as printed: 19,986,768). View filing ↗
Section 06, 2024 vote. Form 8-K, filed 2024-05-24. Item 5.07 · say-on-pay result. As reported: 98.54% (votes for as printed: 20,622,511). View filing ↗
Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
Section 09b board cost (computed). Computed. Cash 508,670 + equity 1,553,777 + all other 0 = 2,062,447, summed across the director compensation table rows.
Natera, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Natera, Inc.'s own proxy. As printed: 14,957,319. View filing ↗
GeneDx Holdings Corp., Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in GeneDx Holdings Corp.'s own proxy. As printed: 13,547,219. View filing ↗
Castle Biosciences Inc (subject), Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Castle Biosciences Inc's own proxy. As printed: 6,786,771. View filing ↗
Section 10a, GeneDx Holdings Corp. reciprocity. DEF 14A. GeneDx Holdings Corp. names Castle Biosciences Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗